12-Step Facilitation for the Dually Diagnosed
为双重诊断患者提供 12 步便利
基本信息
- 批准号:6970257
- 负责人:
- 金额:$ 35.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:alcoholism /alcohol abuse therapybehavior therapybehavioral /social science research tagclinical researchcomorbiditydrug abuse therapyhuman subjecthuman therapy evaluationmajor depressionmental disordersmental health counselingoutcomes researchpatient care managementpatient oriented researchself helpsocial support networksubstance abuse related disordertherapy compliance
项目摘要
DESCRIPTION (provided by applicant): Although there has been relatively little work on 12-step treatment for seriously mentally ill patients, extant literature indicates that dually diagnosed individuals attend traditional 12-step programs such as AA, NA, and CA at rates comparable to singly diagnosed substance abusers, and that participation is associated with decreases in substance use. Specialized 12-step programs for the dually diagnosed, developed over the past 10 years, may offer additional benefits. In order to maximize the effectiveness of specialized and traditional 12-step programs for dually diagnosed individuals, specially adapted 12-step facilitation (TSF) treatment for the dually diagnosed should be developed and tested. Standard TSF should be modified to address the special needs of dually diagnosed individuals, mesh with specialized 12-step programs available in the area, and address barriers to attendance, participation, and engagement experienced by the dually diagnosed. We have developed a modified TSF based on the Project MATCH TSF manual.
Modifications to this 12 week individual therapy include: emphasis on specialized 12-step program attendance; readings primarily from specialized 12-step program literature; participation in the second session by a community specialized 12-step program member; case management to assist participants in finding and attending meetings; omission of work on the fourth step; and the addition of topics covering medication compliance and specific social skills needed to negotiate 12-step meetings. In a pilot study with 10 dually diagnosed individuals, participants showed significant decreases in substance use and significant increases in 12-step attendance after receiving the specialized TSF. Building on this pilot study, the proposed study is a larger Stage Ib study of the modified TSF for seriously mentally ill patients engaged in dual diagnosis treatment. Participants with a psychotic or major affective disorder will be randomized to modified TSF (n=90) vs. treatment as usual (n=45). Participants will be followed for a total of 48 weeks. Assessments will include rigorous diagnosis and measures of alcohol and other drug use, consequences, psychiatric symptoms, 12-step behaviors, 12-step specific and non-specific change mechanisms, and social support. Specific Aims of the study include assessment of the integrity of the planned intervention and assessment battery; tests of the effectiveness of the adapted TSF relative to treatment as usual; determination of whether psychiatric diagnosis moderates treatment response; and investigation of causal mechanisms of response to treatment.
描述(由申请人提供):虽然对严重精神疾病患者的12步治疗的研究相对较少,但现有文献表明,双重诊断的个体参加传统的12步治疗项目(如AA、NA和CA)的比例与单一诊断的药物滥用者相当,而且参与与药物使用的减少有关。在过去的10年里,专门针对双重诊断的12步治疗方案可能会带来额外的好处。为了最大限度地提高对双重诊断个体的专业和传统12步方案的有效性,应该开发和测试专门适用于双重诊断个体的12步促进(TSF)治疗。标准的TSF应进行修改,以满足双重诊断个体的特殊需求,与该地区现有的专业12步计划相结合,并解决双重诊断患者在出席、参与和参与方面遇到的障碍。我们根据Project MATCH TSF手册开发了一个修改后的TSF。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Parks Bogenschutz其他文献
Michael Parks Bogenschutz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Parks Bogenschutz', 18)}}的其他基金
Topiramate as a treatment for Co-occurring AUD and PTSD
托吡酯治疗同时发生的 AUD 和 PTSD
- 批准号:
10473681 - 财政年份:2018
- 资助金额:
$ 35.88万 - 项目类别:
Topiramate as a treatment for Co-occurring AUD and PTSD
托吡酯治疗同时发生的 AUD 和 PTSD
- 批准号:
10237285 - 财政年份:2018
- 资助金额:
$ 35.88万 - 项目类别:
Comparing Interventions for Opioid Dependent Patients Presenting in Medical EDs
比较对就诊于急诊室的阿片类药物依赖患者的干预措施
- 批准号:
9131691 - 财政年份:2013
- 资助金额:
$ 35.88万 - 项目类别:
Comparing Interventions for Opioid Dependent Patients Presenting in Medical EDs
比较对就诊于急诊室的阿片类药物依赖患者的干预措施
- 批准号:
8416794 - 财政年份:2013
- 资助金额:
$ 35.88万 - 项目类别:
Comparing Interventions for Opioid Dependent Patients Presenting in Medical EDs
比较对就诊于急诊室的阿片类药物依赖患者的干预措施
- 批准号:
8735111 - 财政年份:2013
- 资助金额:
$ 35.88万 - 项目类别:
A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders
关于酗酒和并发疾病的研究和指导计划
- 批准号:
8133156 - 财政年份:2007
- 资助金额:
$ 35.88万 - 项目类别:
A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders
关于酗酒和并发疾病的研究和指导计划
- 批准号:
7498960 - 财政年份:2007
- 资助金额:
$ 35.88万 - 项目类别:
A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders
关于酗酒和并发疾病的研究和指导计划
- 批准号:
7313637 - 财政年份:2007
- 资助金额:
$ 35.88万 - 项目类别:
A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders
关于酗酒和并发疾病的研究和指导计划
- 批准号:
7682269 - 财政年份:2007
- 资助金额:
$ 35.88万 - 项目类别:
12-Step Facilitation for the Dually Diagnosed
为双重诊断患者提供 12 步便利
- 批准号:
7115813 - 财政年份:2005
- 资助金额:
$ 35.88万 - 项目类别:
相似海外基金
Digital cognitive-behavior therapy for anxiety and depressive disorders: Building an impactful research project from international partnerships and knowledge exchange in primary care
针对焦虑和抑郁症的数字认知行为疗法:通过初级保健领域的国际合作和知识交流建立一个有影响力的研究项目
- 批准号:
480808 - 财政年份:2023
- 资助金额:
$ 35.88万 - 项目类别:
Miscellaneous Programs
Function of cost bias and effect of cognitive behavior therapy on social anxiety in children and adolescents
成本偏差的作用及认知行为治疗对儿童青少年社交焦虑的影响
- 批准号:
23K02970 - 财政年份:2023
- 资助金额:
$ 35.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Combined Dialectical Behavior Therapy and Digital Cognitive Behavioral Therapy for Insomnia for Adolescents at High Risk for Suicide: A Pilot RCT
辩证行为疗法和数字认知行为疗法相结合治疗自杀高危青少年的失眠:一项试点随机对照试验
- 批准号:
10643478 - 财政年份:2023
- 资助金额:
$ 35.88万 - 项目类别:
A Randomized Clinical Trial Comparing Transdiagnostic Behavior Therapy to Disorder-Specific Psychotherapy in the Recovery of Veterans with Social Anxiety Disorder and Comorbid PTSD Symptomatology
一项随机临床试验,比较跨诊断行为疗法与特定障碍心理疗法在患有社交焦虑症和共病 PTSD 症状的退伍军人康复中的作用
- 批准号:
10746930 - 财政年份:2023
- 资助金额:
$ 35.88万 - 项目类别:
Reducing suicide risk among aging caregivers of persons with AD/ADRD: Adapting, implementing, and evaluating Dialectical Behavior Therapy skills training interventions.
降低 AD/ADRD 患者老年护理人员的自杀风险:调整、实施和评估辩证行为治疗技能培训干预措施。
- 批准号:
10730708 - 财政年份:2023
- 资助金额:
$ 35.88万 - 项目类别:
A Randomized control trial of behavior therapy of tics in Japan. Exploring the behavior model of tics.
日本抽动行为治疗的随机对照试验。
- 批准号:
22K13840 - 财政年份:2022
- 资助金额:
$ 35.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Role of Behavior Therapy Combined with Buprenorphine for the Treatment of Opioid Use Disorder
行为疗法联合丁丙诺啡治疗阿片类药物使用障碍的作用
- 批准号:
10440820 - 财政年份:2022
- 资助金额:
$ 35.88万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效
- 批准号:
10429841 - 财政年份:2022
- 资助金额:
$ 35.88万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效
- 批准号:
10656415 - 财政年份:2022
- 资助金额:
$ 35.88万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression - supplement
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效 - 补充
- 批准号:
10794868 - 财政年份:2022
- 资助金额:
$ 35.88万 - 项目类别:














{{item.name}}会员




